Harmony Foods files routine FDA paperwork for CVS prebiotic gummies
A routine FDA filing for CVS prebiotic gummies confirms the legal process behind store-brand health claims, but public records show no warning, recall, or price
By Foodie Pundit Newsroom - Published - Updated - Section: Food Prices

Key points
- Regulations.gov recorded an FDA-associated docket item on September 3, 2026, naming Harmony Foods LLC and CVS No Sugar Added Prebiotic Fiber Gummies 72ct.
- The supplied record does not show a label decision, enforcement action, price change, recall, or effect on grocery logistics.
- No lobbying, contract, grant, ownership, or payment records were supplied, so no money-and-influence link is documented.
- The next concrete item to watch is a subsequent dated FDA or Regulations.gov action tied to FDA-2026-S-0024-0403; the supplied record lists no deadline.
Picture the scene. You are walking under the bright, buzzing fluorescent lights of a standard chain drugstore, navigating the quiet rows of the supplement aisle. You stop in front of a shelf stocked with plastic bottles, scan the options, and pull down a bottle of store-brand chewables.
The label on the front reads CVS No Sugar Added Prebiotic Fiber Gummies. Right beneath that brand name sits a specific line of text that catches your eye, promising that the product "Supports Digestive Health." To most shoppers standing in the middle of the pharmacy aisle, taking that bottle off the shelf, dropping it into a shopping basket, and walking up to the register feels like the entire story.
It seems like a quick, everyday retail exchange where a consumer trades money for a daily supplement. But that simple shelf-side decision is not the end of the transaction. In reality, that modest bottle on the shelf is directly tied to a massive public record sitting inside an official federal database maintained by the United States government.
Every time a product like this hits retail shelves, it carries a paper trail that reaches far beyond the front door of your local corner drugstore. The single bottle of chewable gummies in your hand is linked to a federal regulatory paper trail that traces the exact claims printed on its packaging back to government records in Washington. The words on the plastic container are not merely marketing copy tossed onto a label by a brand design team; they represent a specific, legally binding statement submitted to federal regulators. That single phrase about supporting digestive health forms a direct bridge between a casual impulse purchase at the pharmacy register and a permanent entry in a public government archive.
That connection became official on Sept. 3, 2026. On that date, a company named Harmony Foods LLC formally submitted a structure/function claim notification to the Food and Drug Administration. The federal agency logged the filing into its official records under Docket FDA-2026-S-0024, assigning the specific submission the unique document identification tag of Document ID FDA-2026-S-0024-0403.
The filing itself carries a precise, formal title in the government records: "Harmony Foods LLC - CVS No Sugar Added Prebiotic Fiber Gummies 72ct - Supports Digestive Health." Far from being an unusual corporate maneuver or a secret government investigation, this filing represents a completely standard, mandatory regulatory step required under federal law for dietary supplements sold across the country, as reported by Regulations. gov.
To understand why this administrative paperwork exists in the first place, you have to look at the legal framework that governs the entire supplement aisle. Under the Dietary Supplement Health and Education Act of 1994, commonly known across the food and drug sector as DSHEA, manufacturers who intend to make structure or function claims about their products are subject to strict federal reporting rules. A structure or function claim is a specific type of statement that describes how a product or its ingredients affect the normal structure or function of the human body, such as asserting that a product supports digestive health. Under the statutory guidelines established by DSHEA in 1994, any manufacturer making these specific statements must officially notify the Food and Drug Administration no later than 30 days after first placing the product on the market for retail sale.
That 30-day post-market notification rule provides a clear window into the actual timeline of when this bottle made its way onto retail shelves. Because Harmony Foods LLC submitted its official structure/function notification on Sept. 3, 2026, the regulatory calendar indicates that the chewable fiber gummies were almost certainly placed onto CVS store shelves sometime during August or early September 2026. The filing date acts as a regulatory anchor, confirming that the product was already entering consumer hands or actively sitting on retail display racks right around the time the paperwork landed on administrative desks at the federal agency.
When people hear that a dietary supplement has been logged in an official federal government database, it is easy to assume something has gone wrong. However, it is essential to understand what this specific filing is not. This official submission is not a product recall.
It is not an FDA warning letter. It is not a safety alert, a consumer advisory, or a notice of product contamination. Instead, this filing is a standard, routine, and entirely mandatory administrative declaration.
It is simply a commercial entity fulfilling its baseline legal obligation under federal law to document the precise language and health claims used for a private-label product sold under the CVS brand name.
The official government documentation explicitly identifies two distinct commercial entities involved in bringing this product to retail aisles. The public record names Harmony Foods LLC as the petitioner and manufacturer responsible for filing the official structure/function notification with the federal government. On the commercial side of the arrangement, CVS is designated as the distributor and private-label brand owner whose name sits prominently across the packaging.
While CVS is the brand name that consumers see on store shelves, Harmony Foods LLC is the underlying manufacturing enterprise handling the required regulatory submissions behind the scenes. This division of responsibility is a standard arrangement in the modern private-label retail landscape, where brand owners partner with specialized manufacturing entities to produce store-brand goods while maintaining strict compliance with federal filing mandates.
Inside the federal bureaucracy, oversight of these structure/function claim notifications falls under a specific branch of the government apparatus. Federal administrative responsibility for reviewing and cataloging these filings rests with the Center for Food Safety and Applied Nutrition, operating through its dedicated Office of Dietary Supplement Programs within the Food and Drug Administration. When companies like Harmony Foods LLC submit their documentation, this specialized office receives, indexes, and maintains the record within the agency's public dockets. This centralized system ensures that every structure or function claim made on dietary supplement packaging across the United States is archived and available for agency oversight and public inspection.
Crucially, the simple act of the government receiving a structure/function notification does not carry the weight that many consumers might assume. Receipt of a notification by federal regulators does not equal FDA approval, nor does it represent an official scientific endorsement from the United States government. The Food and Drug Administration does not pre-approve dietary supplement labels or certify that structure/function claims are medically proven before products hit the market.
Instead, the agency maintains the submission on record. If federal regulators at the Center for Food Safety and Applied Nutrition later evaluate the product and determine that its digestive health claim is unsubstantiated, misleading, or functioning unlawfully as an unapproved drug claim, the agency holds the authority to intervene. In those instances, the FDA can issue a formal public warning letter to the company or require immediate label revisions to bring the product into full legal compliance.
A close inspection of the public docket entry reveals strict boundaries regarding what information is actually shared with the public and what remains private. The available government record is purely administrative and intentionally narrow. The public filing contains zero information regarding sales projections, corporate revenue expectations, or volume forecasts for the product line.
You will not find manufacturing contract terms, unit costs, wholesale pricing figures, or distribution expense breakdowns in the record. The docket is entirely silent on freight details, shipping logistics, supply chain arrangements, or retail profit margins.
Instead of detailed commercial metrics, the public record consists strictly of basic regulatory markers and essential product identifiers. The accessible entry contains only the formal filing tags: Docket FDA-2026-S-0024 and Document ID FDA-2026-S-0024-0403. It documents the exact 72-count package size listed on the retail bottle, identifies Harmony Foods LLC as the petitioner, lists CVS as the brand distributor, and explicitly logs the designated health claim that the product "Supports Digestive Health." Everything else regarding the commercial realities of production, transportation, and store pricing stays strictly within private corporate accounting offices.
For consumers walking through the pharmacy aisle, understanding these administrative filings provides a clear view into how the supplement industry operates behind the scenes. The bottle of 72-count chewables sitting on the shelf at CVS represents a carefully regulated intersection of private-label retail, third-party manufacturing, and federal disclosure rules. When you pay for a bottle at the register, part of what you are paying for is the extensive administrative structure that keeps commercial health claims logged in public government archives.
For now, this Sept. 3, 2026 submission stands as a completely routine administrative entry in the federal registry. The filing reflects standard corporate compliance with the Dietary Supplement Health and Education Act of 1994, marking the official arrival of the CVS No Sugar Added Prebiotic Fiber Gummies on the retail scene. Unless regulatory authorities at the Office of Dietary Supplement Programs raise questions down the road, the record remains a simple document of record.
Any future shift in the status of this product would require additional public paperwork, such as an official agency warning letter, a formal close-out letter, or further public filings posted directly to Docket FDA-2026-S-0024. Until then, the filing remains a quiet, factual bridge connecting a federal database in Washington to a 72-count bottle of prebiotic gummies sitting under the store lights of your local drugstore.